BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kwak MS, Cha JM, Lee HH, Choi YS, Seo SI, Ko KJ, Park DI, Kim SH, Kim TJ. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study. J Gastroenterol Hepatol 2019;34:1018-26. [PMID: 30447025 DOI: 10.1111/jgh.14542] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Keshav N, Ammankallu R, Shashidhar, Paithankar JG, Baliga MS, Patil RK, Kudva AK, Raghu SV. Dextran sodium sulfate alters antioxidant status in the gut affecting the survival of Drosophila melanogaster. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03349-2] [Reference Citation Analysis]
2 Seo HI, Kwon SC, Kwak JY. Protective effects of sigma 1 receptor agonist PRE084 on 2,4,6-trinitrobenzene sulfonic acid-induced experimental colitis in mice. Ann Surg Treat Res 2022;103:160-8. [PMID: 36128036 DOI: 10.4174/astr.2022.103.3.160] [Reference Citation Analysis]
3 Hutfless S, Jasper RA, Tilak A, Ghosh T, Kedia S, Liu S, Urrunaga NH, Josephson M, Narang A, Miller S, Chen PH, Joseph S, Brant SR. A Systematic Review of Crohn's Disease Case Definitions in Administrative or Claims Databases. Inflamm Bowel Dis 2022:izac131. [PMID: 35857336 DOI: 10.1093/ibd/izac131] [Reference Citation Analysis]
4 Chen L, Zhang C, Cao J, Bei G, Wang X, Miao Z. Yiyi Fuzi Baijiang Decoction Alleviates Ulcerative Colitis Partly by Regulating TLR4-Mediated PI3K/Akt and NF-κB Pathways. Evid Based Complement Alternat Med 2022;2022:8780514. [PMID: 35211182 DOI: 10.1155/2022/8780514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Kim S, Park Y, Kim SP, Lee SH, Oh SH, Yang S, Yoon H, Kim KM. Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data. Dig Dis Sci. [DOI: 10.1007/s10620-021-07328-0] [Reference Citation Analysis]
6 Joung EJ, Cao L, Gwon WG, Kwon MS, Lim KT, Kim HR. Meroterpenoid-Rich Ethanoic Extract of Sargassum macrocarpum Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice. Foods 2022;11:329. [PMID: 35159480 DOI: 10.3390/foods11030329] [Reference Citation Analysis]
7 Kuenzig ME, Fung SG, Marderfeld L, Mak JWY, Kaplan GG, Ng SC, Wilson DC, Cameron F, Henderson P, Kotze PG, Bhatti J, Fang V, Gerber S, Guay E, Kotteduwa Jayawarden S, Kadota L, Maldonado D F, Osei JA, Sandarage R, Stanton A, Wan M, Benchimol EI; InsightScope Pediatric IBD Epidemiology Group. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology 2022;162:1147-1159.e4. [PMID: 34995526 DOI: 10.1053/j.gastro.2021.12.282] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
8 Lee JY, Oh K, Hong HS, Kim K, Hong SW, Park JH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Lee HS, Jo KW, Park SH. Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea. BMC Gastroenterol 2021;21:390. [PMID: 34670529 DOI: 10.1186/s12876-021-01973-5] [Reference Citation Analysis]
9 Kim GH, Lee YC, Kim TJ, Kim ER, Hong SN, Chang DK, Kim YH. Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study. J Crohns Colitis 2021:jjab162. [PMID: 34499125 DOI: 10.1093/ecco-jcc/jjab162] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
10 Park J, Park S, Lee SA, Park SJ, Cheon JH. Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management. Korean J Intern Med 2021. [PMID: 34344146 DOI: 10.3904/kjim.2021.114] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Park YE, Lee J, Park J, Choi JH, Heo NY, Park SH, Lee YK, Kim TO. Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology. Korean J Gastroenterol 2021;78:37-47. [PMID: 34312356 DOI: 10.4166/kjg.2021.053] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Choi S, Moon W. [Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?]. Korean J Gastroenterol 2021;77:220-6. [PMID: 34035199 DOI: 10.4166/kjg.2021.067] [Reference Citation Analysis]
13 Olfatifar M, Zali MR, Pourhoseingholi MA, Balaii H, Ghavami SB, Ivanchuk M, Ivanchuk P, Nazari SH, Shahrokh S, Sabour S, Khodakarim S, Aghdaei HA, Rohani P, Mehralian G. The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study. BMC Gastroenterol 2021;21:204. [PMID: 33957874 DOI: 10.1186/s12876-021-01745-1] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
14 Takagi T, Uchiyama K, Kajiwara-Kubota M, Kashiwagi S, Toyokawa Y, Hotta Y, Tanaka M, Inoue K, Dohi O, Yoshida N, Kamada K, Ishikawa T, Konishi H, Kishimoto M, Yagi N, Naito Y, Itoh Y. The efficacy of linked color imaging for the endoscopic diagnosis of mucosal healing in quiescent ulcerative colitis. J Gastroenterol Hepatol 2021. [PMID: 33710655 DOI: 10.1111/jgh.15489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jo UH, Lee JY, Lee H, Kim DY, Kang S, Koh SJ, Park H. Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population. J Dermatol 2021;48:431-8. [PMID: 33608949 DOI: 10.1111/1346-8138.15676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Yoon JY, Cha JM, Lee CK, Park YS, Huh KC, Shin JE, Kim YS, Eun CS, Yoon SM, Cheon JH, Park YS, Ye BD, Lee Y, Kim Y, Kim HJ; MOSAIK study group of the Korean Association for the Study of Intestinal Diseases (KASID). Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea: Results from a hospital-based inception cohort study (MOSAIK). J Gastroenterol Hepatol 2021;36:2149-56. [PMID: 33555067 DOI: 10.1111/jgh.15435] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Park J, Cheon JH. Incidence and Prevalence of Inflammatory Bowel Disease across Asia. Yonsei Med J 2021;62:99-108. [PMID: 33527789 DOI: 10.3349/ymj.2021.62.2.99] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
18 Heo CM, Kim TJ, Kim ER, Hong SN, Chang DK, Yang M, Kim S, Kim YH. Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study. Sci Rep 2021;11:2025. [PMID: 33479464 DOI: 10.1038/s41598-021-81657-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wei S, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJQ, Koram N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Review of Gastroenterology & Hepatology 2021;15:275-89. [DOI: 10.1080/17474124.2021.1840976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
20 Jin HY, Lim JS, Lee Y, Choi Y, Oh SH, Kim KM, Yoo HW, Choi JH. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr 2021;21:35. [PMID: 33446154 DOI: 10.1186/s12887-021-02496-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Son H, Kang Y. Coping Processes of Patients with Ostomies in South Korea: A Focus Group Study. Healthcare (Basel) 2020;9:21. [PMID: 33375414 DOI: 10.3390/healthcare9010021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18:56-66. [PMID: 33033392 DOI: 10.1038/s41575-020-00360-x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 130] [Article Influence: 61.5] [Reference Citation Analysis]
23 Thomas SS, Cha Y, Kim K. Perilla Oil Alleviates High-Fat Diet-Induced Inflammation in the Colon of Mice by Suppressing Nuclear Factor-Kappa B Activation. Journal of Medicinal Food 2020;23:818-26. [DOI: 10.1089/jmf.2019.4675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yeshi K, Ruscher R, Hunter L, Daly NL, Loukas A, Wangchuk P. Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products. J Clin Med 2020;9:E1273. [PMID: 32354192 DOI: 10.3390/jcm9051273] [Cited by in Crossref: 19] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
25 Kwak MS, Cha JM, Ahn JH, Chae MK, Jeong S, Lee HH. Practical strategy for optimizing the timing of anti-tumor necrosis factor-α therapy in Crohn disease: A nationwide population-based study. Medicine (Baltimore) 2020;99:e18925. [PMID: 32150045 DOI: 10.1097/MD.0000000000018925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Choi YI, Kim TJ, Park DK, Chung JW, Kim KO, Kwon KA, Kim YJ. Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease. Int J Colorectal Dis. 2019;34:1713-1721. [PMID: 31471699 DOI: 10.1007/s00384-019-03368-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Gao W, Wang C, Yu L, Sheng T, Wu Z, Wang X, Zhang D, Lin Y, Gong Y. Chlorogenic Acid Attenuates Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice through MAPK/ERK/JNK Pathway. Biomed Res Int 2019;2019:6769789. [PMID: 31139644 DOI: 10.1155/2019/6769789] [Cited by in Crossref: 19] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]